BVS857 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
1	球脊髄性筋萎縮症	4

1. 球脊髄性筋萎縮症

臨床試験数 : 18 / 薬物数 : 15 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 17

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-002608-15-DE (EUCTR)	15/08/2014	15/04/2014	A study of the safety and effectiveness of BVS857 in spinal and bulbar muscular atrophy	A two-part placebo-controlled study to evaluate the safety, tolerability andpreliminary efficacy of ...	Spinal and bulbar muscular atrophy (SBMA) MedDRA version: 18.1;Level: PT;Classification code 1006859 ...	Product Code: BVS857 INN or Proposed INN: -	Novartis Pharma Services AG	NULL	Not Recruiting			Female: no Male: yes	38	Phase 2	United States;Denmark;Germany;Italy
2	EUCTR2013-002608-15-IT (EUCTR)	12/06/2014	14/02/2014	A study of the safety and effectiveness of BVS857 in spinal and bulbar muscular atrophy	A two-part placebo-controlled study to evaluate the safety, tolerability andpreliminary efficacy of ...	Spinal and bulbar muscular atrophy (SBMA) MedDRA version: 16.1;Level: PT;Classification code 1006859 ...	Product Code: BVS857 INN or Proposed INN: NA Other descriptive name: NA	Novartis Farma SpA	NULL	Not Recruiting			Female: no Male: yes	38	Phase 2	United States;Denmark;Germany;Italy
3	EUCTR2013-002608-15-DK (EUCTR)	19/05/2014	21/03/2014	A study of the safety and effectiveness of BVS857 in spinal and bulbar muscular atrophy	A two-part placebo-controlled study to evaluate the safety, tolerability and preliminary efficacy of ...	Spinal and bulbar muscular atrophy (SBMA) MedDRA version: 18.1;Level: PT;Classification code 1006859 ...	Product Code: BVS857	Novartis Pharma Services AG	NULL	Not Recruiting			Female: no Male: yes	38	Phase 2	United States;Denmark;Germany;Italy
4	NCT02024932 (ClinicalTrials.gov)	February 4, 2014	29/12/2013	Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy	A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy o ...	Spinal and Bulbar Muscular Atrophy	Drug: BVS857;Drug: Placebo	Novartis Pharmaceuticals	NULL	Completed	18 Years	N/A	Male	37	Phase 2	United States;Denmark;Germany;Italy

First Previous1Next Last